A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
DEKA Biosciences
Eli Lilly and Company
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Gilead Sciences
City of Hope Medical Center
Rutgers, The State University of New Jersey